The Influence of IL-1B Gene Polymorphisms on H. pylori Infection and Triple Treatment Response Among Jordanian Population

References

• de Korwin J-D, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter. 2017;22:e12411. doi:10.1111/hel.12411
   Web of Science ®Google Scholar
• Venerito M, Vasapolli R, Rokkas T, Malfertheiner P. Gastric cancer: epidemiology, prevention, and therapy. Helicobacter. 2018;23:e12518. doi:10.1111/hel.12518
   PubMed Web of Science ®Google Scholar
• Kumar S, Dhiman M. Inflammasome activation and regulation during Helicobacter pylori pathogenesis. Microb Pathog. 2018;125:468–474. doi:10.1016/j.micpath.2018.10.012
   Web of Science ®Google Scholar
• de Brito BB, da Silva FA, de Melo FF. Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis. World J Clin Oncol. 2018;9(5):83–89. doi:10.5306/wjco.v9.i5.83
   Web of Science ®Google Scholar
• Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984–1010. doi:10.1016/j.jaci.2016.06.033
   PubMed Web of Science ®Google Scholar
• Speaker KJ, Fleshner M. Interleukin-1 beta: a potential link between stress and the development of visceral obesity. BMC Physiol. 2012;12(1):8. doi:10.1186/1472-6793-12-8
   Google Scholar
• Maedler K, Dharmadhikari G, Schumann DM, Størling J. Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther. 2009;9(9):1177–1188. doi:10.1517/14712590903136688
   PubMed Web of Science ®Google Scholar
• El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut. 2001;48(6):743–747. doi:10.1136/gut.48.6.743
   PubMed Web of Science ®Google Scholar
• Ren H-Y, Wen L-S, Geng Y-H, et al. Association between IL-1B gene polymorphisms and Helicobacter pylori infection: a meta-analysis. Microb Pathog. 2019;137:103769. doi:10.1016/j.micpath.2019.103769
   Web of Science ®Google Scholar
• Sugimoto M, Yamaoka Y. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp. 2009;57(1):45–56. doi:10.1007/s00005-009-0007-z
   Web of Science ®Google Scholar
• Akcil G, Dogan I, Cengiz M, et al. The role of interleukin-1 gene polymorphisms and Helicobacter pylori in gastroesophageal reflux disease. Turkish J Gastroenterol. 2015;25(1):81–85. doi:10.5152/tjg.2014.6512
   Web of Science ®Google Scholar
• Ramis IB, Vianna JS, Halicki PCB, et al. Relationship of interleukin-1B gene promoter region polymorphism with Helicobacter pylori infection and gastritis. J Infect Dev Ctries. 2015;9(10):1108–1116. doi:10.3855/jidc.6123
   Web of Science ®Google Scholar
• Figura N. Helicobacter pylori infection and gastric carcinoma: not all the strains and patients are alike. World J Gastrointest Oncol. 2016;8(1):40. doi:10.4251/wjgo.v8.i1.40
   PubMed Web of Science ®Google Scholar
• Zeng Z-R. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003;52(12):1684–1689. doi:10.1136/gut.52.12.1684
   PubMed Web of Science ®Google Scholar
• Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol. 2007;41(12):1169–1177. doi:10.1007/s00535-006-1951-6
   Web of Science ®Google Scholar
• Park M-J, Hyun M-H, Yang J-P, Yoon J-M, Park S. Effects of the interleukin-1β-511 C/T gene polymorphism on the risk of gastric cancer in the context of the relationship between race and H. pylori infection: a meta-analysis of 20,000 subjects. Mol Biol Rep. 2015;42(1):119–134. doi:10.1007/s11033-014-3748-7
   Web of Science ®Google Scholar
• Chen B, Luo M, Zhou X, Lv Y, Su G. Correlation between interleukin-1β-511 C/T polymorphism and gastric cancer in Chinese populations: a meta-analysis. Med Sci Monit. 2016;22:1742–1750. doi:10.12659/MSM.895771
   Web of Science ®Google Scholar
• Ying H-Y, Yu B-W, Yang Z, et al. Interleukin-1B 31 C>T polymorphism combined with Helicobacter pylori-modified gastric cancer susceptibility: evidence from 37 studies. J Cell Mol Med. 2016;20(3):526–536. doi:10.1111/jcmm.12737
   PubMed Web of Science ®Google Scholar
• Santos JC, Ladeira MSP, Pedrazzoli J, Ribeiro ML. Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Brazilian J Med Biol Res. 2012;45(9):811–817. doi:10.1590/S0100-879X2012007500099
   PubMed Web of Science ®Google Scholar
• Tahara T, Shibata T, Yamashita H, et al. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition. Hepatogastroenterology. 2012;59(120):2416–2420. doi:10.5754/hge10605
   Google Scholar
• Kim JJ, Kim N, Hwang S, et al. Relationship of interleukin-1β levels and gastroesophageal reflux disease in Korea. J Gastroenterol Hepatol. 2013;28(1):90–98. doi:10.1111/j.1440-1746.2012.07274.x
   Web of Science ®Google Scholar
• Zhao Y. Association between TNF-α and IL-1β genotypes vs Helicobacter pylori infection in Indonesia. World J Gastroenterol. 2013;19(46):8758. doi:10.3748/wjg.v19.i46.8758
   Web of Science ®Google Scholar
• Sun X, Xu Y, Zhang F, Jing T, Han J, Zhang J. Association between the IL1B −31C > T polymorphism and Helicobacter pylori infection in Asian and Latin American population: a meta-analysis. Microb Pathog. 2015;86:45–52. doi:10.1016/j.micpath.2015.07.010
   Web of Science ®Google Scholar
• Wang Y-M, Li Z-X, Tang F-B, et al. Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population. Tumor Biol. 2016;37(2):2233–2242. doi:10.1007/s13277-015-4022-x
   Google Scholar
• Hwang I-R, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793–1803. doi:10.1053/gast.2002.37043
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Furuta T, Shirai N, et al. Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Expert Opin Pharmacother. 2007;8(16):2701–2717. doi:10.1517/14656566.8.16.2701
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Furuta T, Yamaoka Y. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24(11):1725–1732. doi:10.1111/j.1440-1746.2009.06047.x
   PubMed Web of Science ®Google Scholar
• Take S, Mizuno M, Ishiki K, et al. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. Am J Gastroenterol. 2003;98(11):2403–2408. doi:10.1111/j.1572-0241.2003.07707.x
   PubMed Web of Science ®Google Scholar
• Furuta T. Polymorphism of interleukin-1? Affects the eradication rates of by triple therapy. Clin Gastroenterol Hepatol. 2004;2(1):22–30. doi:10.1016/S1542-3565(03)00288-X
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Furuta T, Shirai N, Ikuma M, Hishida A, ISHIZAKI T. Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy. Clin Pharmacol Ther. 2006;80(1):41–50. doi:10.1016/j.clpt.2006.03.007
   PubMed Web of Science ®Google Scholar
• Kim N, Cho S-I, Yim J-Y, et al. The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea. Helicobacter. 2006;11(2):105–112. doi:10.1111/j.1523-5378.2006.00384.x
   Web of Science ®Google Scholar
• Zhang L, Mei Q, Li QS, Hu YM, Xu JM. The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people. J Clin Pharm Ther. 2010;35(6):713–722. doi:10.1111/j.1365-2710.2009.01140.x
   PubMed Web of Science ®Google Scholar
• Saito Y. First-line eradication for Helicobacter pylori -positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype. World J Gastroenterol. 2015;21(48):13548. doi:10.3748/wjg.v21.i48.13548
   Web of Science ®Google Scholar
• Phiphatpatthamaamphan K, Vilaichone R, Siramolpiwat S, et al. Effect of IL-1 polymorphisms, CYP2C19 genotype and antibiotic resistance on Helicobacter pylori eradication comparing between 10-day sequential therapy and 14-day standard triple therapy with four-times-daily-dosing of amoxicillin in thailand: a prospective randomized study. Asian Pacific J Cancer Prev. 2016;17(4):1903–1907. doi:10.7314/APJCP.2016.17.4.1903
   Google Scholar
• BaniHani MN, Khabour OF, Alzoubi KH, et al. The association between ABCB1 C1236T/C3435T SNPs and H. pylori infection among Jordanians. Genes. 2020;11(1):63. doi:10.3390/genes11010063
   Web of Science ®Google Scholar
• Kuo C-H, Lu C-Y, Shih H-Y, et al. CYP2C19 polymorphism influences Helicobacter pylori eradication. World J Gastroenterol. 2014;20(43):16029. doi:10.3748/wjg.v20.i43.16029
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3(1):10. doi:10.3978/j.issn.2305-5839.2014.11.03
   PubMedGoogle Scholar
• Atherton JC. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997;11(Suppl 1):11–20. doi:10.1046/j.1365-2036.11.s1.3.x
   PubMed Web of Science ®Google Scholar
• Alzoubi KH, Khabour OF, Hassan RE, Qarqaz F, Al-azzam S, Mhaidat N. The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. Int J Clin Pharmacol Ther. 2013;51(08):631–640. doi:10.5414/CP201874
   Web of Science ®Google Scholar
• Khabour OF, ABU-RUMEH L, AL-JARRAH M, JAMOUS M, ALHASHIMI F. Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration. Exp Ther Med. 2014;8(4):1340–1344. doi:10.3892/etm.2014.1909
   Web of Science ®Google Scholar
• Hefler LA, Tempfer CB, Unfried G, et al. A polymorphism of the interleukin-1β gene and idiopathic recurrent miscarriage. Fertil Steril. 2001;76(2):377–379. doi:10.1016/s0015-0282(01)01914-8
   Web of Science ®Google Scholar
• Gehmert S, Velapatiño B, Herrera P, et al. Interleukin-1 beta single-nucleotide polymorphism’s C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians. Am J Trop Med Hyg. 2009;81(5):804–810. doi:10.4269/ajtmh.2009.08-0494
   Web of Science ®Google Scholar
• Haji-Aghamohammadi AA, Bastani A, Miroliaee A, Oveisi S, Safarnezhad S. Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection. Casp J Intern Med. 2016;7(4):267–271.
   PubMed Web of Science ®Google Scholar
• Rad R. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut. 2004;53(8):1082–1089. doi:10.1136/gut.2003.029736
   PubMed Web of Science ®Google Scholar
• Abdiev S, Ahn KS, Khadjibaev A, et al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks. Nagoya J Med Sci. 2010;72(3–4):167–172.
   Web of Science ®Google Scholar
• He B-S, Pan Y-Q, Xu Y-F, Zhu C, Qu -L-L, Wang S-K. Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci. 2011;56(7):2017–2023. doi:10.1007/s10620-010-1557-y
   Web of Science ®Google Scholar
• Caleman Neto A, Rasmussen LT, de LRW, et al. Gene polymorphism of interleukin 1 and 8 in chronic gastritis patients infected with Helicobacter pylori. J Venom Anim Toxins Incl Trop Dis. 2014;20(1):17. doi:10.1186/1678-9199-20-17
   Web of Science ®Google Scholar
• Guo YS, Fujimura M, Lluis F, Tsong Y, Greeley GH, Thompson JC. Inhibitory action of peptide YY on gastric acid secretion. Am J Physiol. 1987;253(3 Pt 1):G298–302. doi:10.1152/ajpgi.1987.253.3.G298
   Web of Science ®Google Scholar
• Beales IL, Calam J. Interleukin 1β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 1998;42(2):227–234. doi:10.1136/gut.42.2.227
   PubMed Web of Science ®Google Scholar
• Chang Y-W, Jang J-Y, Kim N-H, et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer. 2005;114(3):465–471. doi:10.1002/ijc.20724
   Web of Science ®Google Scholar
• Huebinger RM, Smith AD, Zhang Y, et al. Variations of the lung microbiome and immune response in mechanically ventilated surgical patients. PLoS One. 2018;13(10):e0205788. doi:10.1371/journal.pone.0205788
   PubMed Web of Science ®Google Scholar
• Kamada T, Haruma K, Komoto K, et al. Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin. Helicobacter. 1999;4(3):204–210. doi:10.1046/j.1523-5378.1999.99299.x
   Web of Science ®Google Scholar
• Kang HY, Kim SG, Lee MK, Kim JS, Jung HC, Song IS. Effect of Helicobacter pylori eradication according to the IL-8-251 polymorphism in Koreans. J Korean Med Sci. 2012;27(10):1202–1207. doi:10.3346/jkms.2012.27.10.1202
   PubMed Web of Science ®Google Scholar
• Yin Y-W, Hu A-M, Sun -Q-Q, et al. Association between interleukin-8 gene −251 T/A polymorphism and the risk of peptic ulcer disease: a meta-analysis. Hum Immunol. 2013;74(1):125–130. doi:10.1016/j.humimm.2012.09.006
   PubMed Web of Science ®Google Scholar